SEC Tracker
Get the app

Guardant Health GH

Musa Tariq (Director) plans to sell 116 GH shares, about $18,942

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Jul 16, 2026
  2. Broker: Charles Schwab & Co., Inc.
  3. Shares acquired by: Restricted Stock Lapse
  4. 10b5-1 plan adopted: Dec 17, 2025

All of Musa Tariq's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 116 shares at $163.29 on Jul 16, 2026 · Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Guardant Health files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8071 and related industry codes: the same peer list as the financial tables.

  1. Lumexa Imaging Holdings LMRI
  2. RadNet RDNT public float $4.1B, Jun 30, 2025
  3. Caris Life Sciences CAI public float $3.9B, Jun 30, 2025
  4. Exact Sciences EXAS public float $10.0B, Jun 30, 2025
  5. BillionToOne BLLN

Data on this page was fetched . The filing on SEC.gov is the record.